Berger Mark Stanley 4
4 · Actinium Pharmaceuticals, Inc. · Filed Sep 3, 2021
Insider Transaction Report
Form 4
Berger Mark Stanley
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-09-01+67,164→ 67,164 totalExercise: $6.07Exp: 2031-09-01→ Common Stock (67,164 underlying)
Footnotes (2)
- [F1]This price represents the closing price of the Company's common stock on the date of the board of directors approval of the grant.
- [F2]Pursuant to the terms of the Company's Amended and Restated 2013 Stock Plan and 2019 Stock Plan, 2% of the options will vest each month from September 1, 2021 until fully vested.